BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Brief//FDA catalyst calendar//KO
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Brief — FDA 일정 캘린더
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:event-1@catalystbrief.girapphe.com
DTSTAMP:20261117T024426Z
LAST-MODIFIED:20261117T024426Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:승인 결정일(PDUFA): Apnimed\, Inc. (APMD) — Oxnimbi (AD109)
DESCRIPTION:폐쇄성 수면무호흡증 경구 치료제 Oxnimbi(AD109) 
 신약 허가(NDA) FDA PDUFA 목표 심사일.\n출처: https://www.sec.go
 v/Archives/edgar/data/1745648/000119312526462171/apmd-ex99_1.htm\nhttps://
 catalystbrief.girapphe.com/e/1?lang=ko\n투자 조언이 아닙니다. 일
 정은 변경될 수 있습니다.
URL:https://catalystbrief.girapphe.com/e/1?lang=ko
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
